OCUL Stock Analysis: Buy, Sell, or Hold?
OCUL - Ocular Therapeutix, Inc.
$10.12
0.14 (1.45%)
▲
5d:
+12.51%
30d:
+23.05%
90d:
+24.88%
HOLD
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 04, 2026
Smart Money Distribution
None View Scanner →
Strength: 6.8/10
Get Alerted When OCUL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: OCUL is 8.5% above its trading range ($9.32). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: OCUL is 8.5% above its trading range ($9.32). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: OCUL is currently trading at $10.12, which is considered extended relative to its 30-day fair value range of $8.20 to $9.32.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $8.07, while resistance sits at $10.62.
Market Sentiment: OCUL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.91 (+166.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OCUL is in a strong uptrend. Immediate support is located at $8.07, while resistance sits at $10.62.
Market Sentiment: OCUL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $26.91 (+166.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$8.20 -
$9.32
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding OCUL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+8.5% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 166.0% below Wall St target ($26.91)
Trading Range Analysis
30-Day Trading Range
$8.20 -
$9.32
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$8.07
Resistance Level
$10.62
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.64
Wall Street Target
$26.91
(+166.0%)
Revenue Growth (YoY)
0.8%
Share & Embed Analysis
Last updated: June 24, 2026 1:24 AM ET
Data refreshes hourly during market hours. Next update: 2:24 AM
Data refreshes hourly during market hours. Next update: 2:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OCUL showing a specific setup today?
Insider Activity (6 Months)
1
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Peter Kaiser
SELL
2810 shares
2026-02-23
Pravin Dugel
SELL
20056 shares
2026-02-23
Sanjay Nayak
SELL
1759 shares
2026-02-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 62 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 55 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 57 HOLD |
Advanced OCUL Option Strategies
Professional options setups generated by AI based on today's OCUL price and gamma walls.
